Phillyrin attenuates high glucose-induced ferroptosis in gingival cells through the activation of 5′ adenosine monophosphate-activated protein kinase signaling

Delayed wound healing in diabetes involves multiple factors, with ferroptosis being one of the key mechanisms. Ferroptosis, marked by iron accumulation and lipid peroxidation, has been implicated in the pathogenesis of various diseases; however, its role in oral wound healing remains unclear. Here, we evaluated its involvement in impaired wound healing, as well as the therapeutic effects of phillyrin, a natural lignan with the potential to ameliorate oxidative stress and diabetic complications. Smulow–Glickman (S-G) gingival epithelial cells were exposed to high-glucose conditions, followed by treatment with phillyrin. PrestBlue assay and 2 well culture-insert were utilized to assess cell viability and wound healing capacity, respectively. Lipid peroxidation and oxidative stress were determined using commercial assay kits to measure malondialdehyde (MDA) and 8-hydroxy-2-deoxyguanosine (8-OHdG), respectively. Intracellular Fe 2+ was measured using FerroOrange fluorescent probe. High glucose, like the ferroptosis inducer erastin, reduced cell viability and wound-healing capacity, whereas ferroptosis inhibitor Ferrostatin-1 or phillyrin treatment conferred comparable protection. Also, we showed that the characteristics of ferroptosis were elevated in high glucose-treated cells, while phillyrin administration reduced these features in a dose-dependent manner. More importantly, we found that this effect may result from phillyrin restoring high-glucose-suppressed 5′ adenosine monophosphate-activated protein kinase (AMPK) phosphorylation, thereby regulating anti-ferroptotic factors and enhancing cellular resilience against ferroptosis. These findings suggest that phillyrin may improve impaired oral wound healing in diabetes through the activation of AMPK and upregulation of anti-ferroptotic mechanisms, underscoring its promise in the treatment of complications associated with diabetes.

Authors

Institutions

Publication Details

Journal
Journal of Dental Sciences
Published
2025-12-01
DOI
https://doi.org/10.1016/j.jds.2025.12.014
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phillyrin attenuates high glucose-induced ferroptosis in gingival cells through the activation of 5′ adenosine monophosphate-activated protein kinase signaling

Pei-Fang Hsieh, Pei-Ling Hsieh
Journal of Dental Sciences
Ferroptosis and cancer prognosis
article

Phillyrin attenuates high glucose-induced ferroptosis in gingival cells through the activation of 5′ adenosine monophosphate-activated protein kinase signaling

Pei-Fang Hsieh, Pei-Ling Hsieh
article en

Abstract

Delayed wound healing in diabetes involves multiple factors, with ferroptosis being one of the key mechanisms. Ferroptosis, marked by iron accumulation and lipid peroxidation, has been implicated in the pathogenesis of various diseases; however, its role in oral wound healing remains unclear. Here, we evaluated its involvement in impaired wound healing, as well as the therapeutic effects of phillyrin, a natural lignan with the potential to ameliorate oxidative stress and diabetic complications. Smulow–Glickman (S-G) gingival epithelial cells were exposed to high-glucose conditions, followed by treatment with phillyrin. PrestBlue assay and 2 well culture-insert were utilized to assess cell viability and wound healing capacity, respectively. Lipid peroxidation and oxidative stress were determined using commercial assay kits to measure malondialdehyde (MDA) and 8-hydroxy-2-deoxyguanosine (8-OHdG), respectively. Intracellular Fe 2+ was measured using FerroOrange fluorescent probe. High glucose, like the ferroptosis inducer erastin, reduced cell viability and wound-healing capacity, whereas ferroptosis inhibitor Ferrostatin-1 or phillyrin treatment conferred comparable protection. Also, we showed that the characteristics of ferroptosis were elevated in high glucose-treated cells, while phillyrin administration reduced these features in a dose-dependent manner. More importantly, we found that this effect may result from phillyrin restoring high-glucose-suppressed 5′ adenosine monophosphate-activated protein kinase (AMPK) phosphorylation, thereby regulating anti-ferroptotic factors and enhancing cellular resilience against ferroptosis. These findings suggest that phillyrin may improve impaired oral wound healing in diabetes through the activation of AMPK and upregulation of anti-ferroptotic mechanisms, underscoring its promise in the treatment of complications associated with diabetes.

Journal of Dental Sciences
Chung Hwa University of Medical Technology (TW), China Medical University (TW), E-Da Hospital (TW), Chung Shan Medical University Hospital (TW), Chung Shan Medical University (TW)
Good health and well-being
Openalex Percentile: Top 28%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.